Anzeige
❌
Mehr »
Mittwoch, 21.10.2026 - Börsentäglich über 12.000 News
Gewinnsprung und Milliardenmarkt im Rücken - 40 Mio. USD Auftragsbestand durch Methan-Altlasten
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IB

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
21.10.26 | 08:20
16,280 Euro
+0,49 % +0,080
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
16,18016,32011:51
16,18016,36011:51

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoIBA SA: Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix5
MoIBA SA: IBA launches NEPTIS Perform Duo, one synthesizer module from tracer development to routine production3
MoXETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.20264.858Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen. 1. US88025U1097 10X GENOMICS INC 2. NL0000852564 AALBERTS NV 3. SE0016589188 ELECTROLUX AB 4. SE0000115446...
► Artikel lesen
FrIBA SA: IBA and Framatome join forces to industrialize Astatine-211 production for cancer therapies8
DoIBA SA: IBA selected to support the US expansion of a leading radiopharmaceutical producer with an order for 12 Cyclone KIUBE systems11
01.10.IBA SA: IBA and Telix strengthen ties through agreement to distribute ARTMS's QIS375IBA to offer QUANTM Irradiation System solid-target technology to cyclotron users worldwide, scaling local production of radiometals for theranostics Louvain-la-Neuve, Belgium - October 1st, 2026...
► Artikel lesen
29.09.IBA SA: IBA signs contract to install the first proton therapy center in central Italy, in Rome411Louvain-La-Neuve, Belgium, September 29, 2026 at 7 a.m. CEST - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of...
► Artikel lesen
28.09.IBA SA: Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide315New expert-led services platform will help healthcare providers develop, implement, and optimize proton therapy and advanced radiation oncology programs across the full care delivery lifecycle PHILADELPHIA...
► Artikel lesen
ION BEAM APPLICATIONS Aktie jetzt für 0€ handeln
27.09.IBA SA: IBA Launches QUASAR Penta-Guide Performance Phantom3
25.09.IBA SA: IBA to coordinate LIFEDESTINY, a new European LIFE project to advance sustainable PFAS remediation5
02.09.IBA SA: IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications423Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS...
► Artikel lesen
27.08.IBA H1 2026 slides: proton therapy drives 66% EBIT jump33
27.08.IBA SA: IBA reports Half Year 2026 results, on track with its improved profitability trajectory586Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance...
► Artikel lesen
14.07.IBA SA: IBA - Regulated information36
30.06.IBA SA: The National Proton Therapy Center of Portugal will be equipped with two IBA ProteusONE solutions25
25.06.IBA SA: IBA to install the first proton therapy center in Brazil in Rio de Janeiro1.162Louvain-La-Neuve, Belgium, June 25, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions...
► Artikel lesen
17.06.Ion Beam Applications: Aktie legt nach Managementumbau um 7 % zu42
17.06.IBA SA: IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend24
17.06.IBA SA: IBA strengthens its leadership team to support its growth710Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine...
► Artikel lesen
10.06.IBA SA: IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy1.065Louvain-la-Neuve, Belgium, June 10, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for...
► Artikel lesen
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1